Carlos Souza Do Nascimento
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Setd1 Histone 3 Lysine 4 Methyltransferase Complex Components in Epigenetic Regulation
SETD1 HISTONE 3 LYSINE 4 METHYLTRANSFERASE COMPLEX COMPONENTS IN EPIGENETIC REGULATION Patricia A. Pick-Franke Submitted to the faculty of the University Graduate School in partial fulfillment of the requirements for the degree Master of Science in the Department of Biochemistry and Molecular Biology Indiana University December 2010 Accepted by the Faculty of Indiana University, in partial fulfillment of the requirements for the degree of Master of Science. _____________________________________ David Skalnik, Ph.D., Chair _____________________________________ Kristin Chun, Ph.D. Master’s Thesis Committee _____________________________________ Simon Rhodes, Ph.D. ii DEDICATION This thesis is dedicated to my sons, Zachary and Zephaniah who give me great joy, hope and continuous inspiration. I can only hope that I successfully set a good example demonstrating that one can truly accomplish anything, if you never give up and reach for your dreams. iii ACKNOWLEDGEMENTS I would like to thank my committee members Dr. Skalnik, Dr. Chun and Dr. Rhodes for allowing me to complete this dissertation. They have been incredibly generous with their flexibility. I must make a special thank you to Jeanette McClintock, who willingly gave her expertise in statistical analysis with the Cfp1 microarray data along with encouragement, support and guidance to complete this work. I would like to thank Courtney Tate for her ceaseless willingness to share ideas, and her methods and materials, and Erika Dolbrota for her generous instruction as well as the name of a good doctor. I would also like to acknowledge the superb mentorship of Dr. Jeon Heong Lee, PhD and the contagious passion and excitement for the life of science of Dr. -
The ASD-Associated CNV 16P11.2: Functional Study of the Candidate Gene
The ASD-associated CNV 16p11.2: Functional study of the candidate gene QPRT Dissertation zur Erlangung des Doktorgrades der Naturwissenschaften vorgelegt beim Fachbereich 15 der Johann Wolfgang Goethe-Universität in Frankfurt am Main von Denise Haslinger aus Braunau am Inn, Österreich Frankfurt 2018 D 30 vom Fachbereich 15 der Johann Wolfgang Goethe-Universität als Dissertation angenommen. Dekan: Prof. Dr. Sven Klimpel 1. Gutachterin: Prof. Dr. Amparo Acker-Palmer 2. Gutachterin: Prof. Dr. Christine M. Freitag Datum der Disputation: ………………………………………………. Dissertation Denise Haslinger Index Index Index ............................................................................................................................................................................ I List of figures ............................................................................................................................................................. IV List of tables .............................................................................................................................................................. IV List of abbreviations used in this study ....................................................................................................................... V List of genes discussed in this study ......................................................................................................................... VII Vorwort .................................................................................................................................................................... -
Influence of Vitamin D on Genome-Wide Expression in Natural Killer Cells
Aus dem Bereich Klinische Medizin der Medizinischen Fakultät der Universität des Saarlandes, Homburg/Saar Influence of Vitamin D on Genome-Wide Expression in Natural Killer Cells Dissertation zur Erlangung des Grades eines Doktors der Medizin der Medizinischen Fakultät der UNIVERSITÄT DES SAARLANDES 2021 vorgelegt von: Konstantinos Christofyllakis geb. am.: 06.05.1988 in Athen, Griechenland Tag der Promotion: 19. April 2021 Dekan: Univ.-Prof. Dr. med- Michael D. Menger Berichterstatter: PD Dr. Frank Neumann Prof. Dr. Markus Hoth The experiments for the present doctoral thesis were conducted at the Clinic for Internal Medicine I - Oncology, Hematology, Clinical Immunology and Rheumatology, as well as at the José Carreras Institute of Saarland University in Homburg (Saar). Konstantinos Christofyllakis Saarland University Medical Center – IMED (bldg. 41) Department of Internal Medicine I Oncology, Hematology, Rheumatology and clinical Immunology Director: Prof. Dr. Stephan Stilgenbauer Kirrberger Strasse 100 66421 Homburg/Saar, Germany Mail: [email protected] TABLE OF CONTENTS Table of Contents ................................................................................................................... i List of Figures ........................................................................................................................iv List of Tables ......................................................................................................................... v 1 Summary ....................................................................................................................... -
Università Degli Studi Di Milano
UNIVERSITÀ DEGLI STUDI DI MILANO DOTTORATO IN PATOLOGIA E NEUROPATOLOGIA SPERIMENTALI Dipartimento di Biotecnologie Mediche e Medicina Traslazionale Curriculum Genetico/XXV Ciclo RARE DE NOVO AND TRANSMITTED COPY NUMBER VARIATIONS IN AUTISM SPECTRUM DISORDERS: IMPLICATIONS FOR FUNCTIONAL NETWORKS OF GENES INVOLVED IN NEUROGENESIS, NEURONAL METABOLISM, SYNAPTIC FUNCTION, NEUROIMMUNITY, INTRACELLULAR SIGNALING AND CHROMATIN REMODELING Settore scientifico disciplinare: MED/03 Tesi di Dottorato di: Dott.ssa Chiara CASTRONOVO Matr. R08592 Docente di riferimento: Prof.ssa Palma FINELLI Tutor: Dott.ssa Maria Teresa BONATI Coordinatore del Dottorato: Prof. Massimo LOCATI Anno Accademico 2011/2012 1 To my husband 2 Index Introduction page 4 1. Autism Spectrum Disorders (ASD) page 5 1.1 Classification and clinical diagnosis page 5 1.2 Etiopathogenesis page 6 1.2.1 Genetic architecture in Autism Spectrum Disorders page 6 1.2.2 Mode of inheritance page 11 1.2.3 Mitochondrial abnormalities in Autism Spectrum Disorders page 12 1.2.4 Immune dysfunctions in Autism Spectrum Disorders page 14 1.2.5 Environmental factors page 18 2. Copy number variations (CNVs) in human genome page 20 2.1 Copy number variations in Autism Spectrum Disorders page 21 3. Neurobiology of Autism Spectrum Disorders page 25 3.1 Neuroanatomical abnormalities in ASD page 25 3.2 ASDs represent a “synaptopathy” page 27 Patients and Methods page 36 4.1 Patients page 37 4.2 Molecular karyotyping by means of array-based Comparative Genomic Hybridization (array CGH) analysis page 39 4.2.1 Extraction of genomic DNA (gDNA) from peripheral blood page 39 4.2.2 gDNA enzymatic restriction digestion page 39 4.2.3 Fluorescent Labeling of DNA by Agilent Genomic DNA Labeling Kit PLUS page 41 4.2.4 Clean-up of Labeled Genomic DNA page 42 4.2.5 Preparation of Labeled Genomic DNA for Hybridization page 42 4.3 Copy Number Variant analysis page 44 Results page 46 5.1 Identification and classification of rare CNVs page 47 Table 3 page 50 5.2. -
(12) Patent Application Publication (10) Pub. No.: US 2009/0203014 A1 WU Et Al
US 20090203 014A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2009/0203014 A1 WU et al. (43) Pub. Date: Aug. 13, 2009 (54) METHOD FOR DIAGNOSINGAUTISM (22) Filed: Dec. 31, 2008 SPECTRUM DSORDER Related U.S. Application Data (75) Inventors: Bai-Lin WU, Newton, MA (US); (63) Continuation-in-part of application No. 12/239,386, Yiping SHEN, Lexington, MA filed on Sep. 26, 2008. (US); David T. MILLER, Westwood, MA (US); Orah S. (60) Provisional application No. 61/018,556, filed on Jan. PLATT, Brookline, MA (US) 2, 2008. Publication Classification Correspondence Address: DAVID S. RESNICK (51) Int. Cl. NIXON PEABODY LLP, 100 SUMMER STREET CI2O I/68 (2006.01) BOSTON, MA 02110-2131 (US) (52) U.S. Cl. ............................................................ 435/6 (73) Assignee: CHILDRENS MEDICAL (57) ABSTRACT CENTER CORPORATION, The present invention provides methods of diagnosing and/or Boston, MA (US) predicting autism spectrum disorder comprising determining the presence of microdeletions and microduplications on (21) Appl. No.: 12/347,411 chromosomes 15 and 16. Patent Application Publication Aug. 13, 2009 Sheet 1 of 10 US 2009/0203014 A1 ... rich w is s Patent Application Publication Aug. 13, 2009 Sheet 2 of 10 US 2009/0203014 A1 V,±)IJI 8I3°50IJI Patent Application Publication Aug. 13, 2009 Sheet 3 of 10 US 2009/0203014 A1 0 §21 §11 0 °50IJI|O3 $1 000'l- Patent Application Publication Aug. 13, 2009 Sheet 4 of 10 US 2009/0203014 A1 1? .§18.02$.§2º.|?º§§§ 891+x0,y0 .§0$.[]|$ Patent Application Publication Aug. 13, 2009 Sheet 5 of 10 US 2009/0203014 A1 WWSWAN OO Patent Application Publication Aug. -
Resistance to Hepatitis C Virus: Potential Genetic and Immunological Determinants
Resistance to hepatitis C virus: potential genetic and immunological determinants Michael Mokhlis Mina A thesis submitted in fulfilment of the requirement for the degree of Doctor of Philosophy The Kirby Institute The University of New South Wales September 2020 GRIS 23/2/21, 6:22 pm Thesis Title and Abstract Declarations Inclusion of Publications Corrected Thesis and Statement Responses Thesis Title Resistance to hepatitis C virus: potential genetic and immunological determinants Thesis Abstract Studies of highly exposed individuals who remain seronegative (HESN) for HIV infection led to the discovery that homozygosity for the d32 mutation in the CCR5 chemokine receptor gene abrogated viral entry into target cells, and was associated with resistance to infection. In addition, evidence for protective immunity has been found in some HESN groups, such as sex workers in the Gambia. Population studies of those at high risk for hepatitis C virus (HCV) infection suggest that a HESN phenotype exists. There is a growing body of evidence for protective immunity, which allows clearance of HCV without seroconversion, and proof-of- principle evidence from in vitro studies that genetic polymorphisms may confer resistance to establishment of infection. This doctoral research project explores evidence for protective immunity, including via genetically programmed variations in host responses and provides evidence that genetic mutations confer resistance against HCV. The data generally strengthens the notion that investigations of naturally occurring